Recruiting

Surgery technique to remove pancreatic tumors while reducing blood loss

Plain-English translation of NCT06164769 on ClinicalTrials.gov ↗ · Source last updated June 2025 · Translation generated June 2026 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

This study is testing a surgical technique for removing noncancerous or borderline pancreatic tumors using a minimally invasive approach. During the surgery, the surgeon will temporarily block blood vessels feeding the pancreas to reduce bleeding and make the tumor easier to remove. The research team will track how well this technique works and how much blood loss occurs during the procedure.

Pancreatic surgery can involve significant blood loss, which can complicate recovery and patient outcomes. This trial exists to see whether blocking blood vessels during tumor removal can safely reduce bleeding and improve surgical results for patients with benign pancreatic tumors.

Do you qualify?

You likely qualify if…

you have a benign or borderline pancreatic tumor confirmed by pathology (such as neuroendocrine tumors, solid pseudopapillary tumors, or cystadenomas)
your tumor is located in the head, neck, or uncinate process of your pancreas
your tumor does not have evidence of blood vessel invasion or spread to other parts of your body
you are a candidate for laparoscopic (minimally invasive) pancreatic surgery with arterial blocking

You likely don't qualify if…

you have a highly malignant (aggressive) pancreatic cancer or a tumor that has infiltrated surrounding tissues or spread
your tumor is located in the body or tail of the pancreas
you cannot undergo the specific surgical technique being tested in this study

What participation looks like

If you qualify, you would undergo laparoscopic pancreatic surgery at the Second Affiliated Hospital of Zhejiang University between March 2023 and May 2026. Before surgery, your doctors will collect your medical history, blood work, and imaging scans. During the procedure, the surgeon will use the blood vessel-blocking technique to remove your tumor. After surgery, the research team will monitor your recovery and record information about blood loss, your clinical response, and any complications to evaluate how well the technique worked.

AI-generated summary from trial data · Jun 7, 2026 · Not medical advice

Trial locations(1 site)

China

the Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang